Yale University Alzheimer's Disease Research Unit — New Haven, Connecticut

Yale University Alzheimer's Disease Research Unit is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Yale University Alzheimer's Disease Research Unit has participated in 2 clinical trials.

Therapeutic areas: Mild Cognitive Impairment, Alzheimer's Disease, Alzheimers Disease.

Sponsors: Alzheimer's Disease Cooperative Study (ADCS), Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale University Alzheimer's Disease Research Unit?

Yale University Alzheimer's Disease Research Unit has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale University Alzheimer's Disease Research Unit conducted?

Yale University Alzheimer's Disease Research Unit has 2 clinical trials on record. Their work covers Mild Cognitive Impairment, Alzheimer's Disease, Alzheimers Disease.

Is Yale University Alzheimer's Disease Research Unit accredited by Crixeo Health?

Yale University Alzheimer's Disease Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale University Alzheimer's Disease Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.